Work

Clinical Efficacy and Safety of Anlotinib Combined with Immune Checkpoint Inhibitors in the Treatment of Advanced Squamous Cell Lung Cancer: A Retrospective Single-Center Study in China

Year: 2024

Type: article

Study design: Observational Study

Source: Current Cancer Drug Targets

DOI: 10.2174/0115680096299425240925073611

Authors: Bin Xu, Chunhua Xu, Li Li, Yuchao Wang

Institutions: Nanjing Brain Hospital, Nanjing Chest Hospital, Nanjing Medical University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404152237

FWCI:

Cites: 27

Cited by:

Related to: 10